View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAVEVA Group 配当と自社株買い配当金 基準チェック /06主要情報1.2%配当利回り0.04%バイバック利回り総株主利回り1.2%将来の配当利回り1.4%配当成長-1.6%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向-185%最近の配当と自社株買いの更新Upcoming Dividend • Jun 30Upcoming dividend of UK£0.24 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 05 August 2022. The company is not currently making a profit and its cash payout ratio is 85%. Trailing yield: 1.7%. Lower than top quartile of British dividend payers (5.2%). Lower than average of industry peers (2.2%).Upcoming Dividend • Dec 30Upcoming dividend of UK£0.13 per shareEligible shareholders must have bought the stock before 06 January 2022. Payment date: 04 February 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.5%).Upcoming Dividend • Jul 01Upcoming dividend of UK£0.23 per shareEligible shareholders must have bought the stock before 08 July 2021. Payment date: 04 August 2021. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.6%).Upcoming Dividend • Dec 31Upcoming Dividend of UK£0.12 Per ShareWill be paid on the 5th of February to those who are registered shareholders by the 7th of January. The trailing yield of 1.4% is below the top quartile of British dividend payers (4.7%), and is lower than industry peers (1.7%).すべての更新を表示Recent updatesお知らせ • Jan 19+ 5 more updatesAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share IndexAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share IndexRecent Insider Transactions • Aug 03CTO and Executive VP of R&D recently sold UK£57k worth of stockOn the 26th of July, Andrew McCloskey sold around 2k shares on-market at roughly UK£23.11 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of UK£252k more than they bought in the last 12 months.Upcoming Dividend • Jun 30Upcoming dividend of UK£0.24 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 05 August 2022. The company is not currently making a profit and its cash payout ratio is 85%. Trailing yield: 1.7%. Lower than top quartile of British dividend payers (5.2%). Lower than average of industry peers (2.2%).Reported Earnings • Jun 09Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: UK£0.21 loss per share (down from UK£0.11 profit in FY 2021). Revenue: UK£1.19b (up 45% from FY 2021). Net loss: UK£62.6m (down 352% from profit in FY 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 12%, compared to a 26% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.Board Change • Jun 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Anne Stevens was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Buying Opportunity • May 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be UK£26.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.Price Target Changed • Apr 28Price target decreased to UK£33.83Down from UK£36.63, the current price target is an average from 16 analysts. New target price is 65% above last closing price of UK£20.54. Stock is down 42% over the past year. The company is forecast to post earnings per share of UK£0.072 for next year compared to UK£0.11 last year.Buying Opportunity • Apr 27Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 32%. The fair value is estimated to be UK£27.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.Board Change • Mar 29High number of new directorsIndependent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021.Recent Insider Transactions • Mar 11CTO and Executive VP of R&D recently sold UK£159k worth of stockOn the 7th of March, Andrew McCloskey sold around 7k shares on-market at roughly UK£24.03 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought UK£320k more than they sold in the last 12 months.Price Target Changed • Feb 28Price target decreased to UK£39.60Down from UK£42.71, the current price target is an average from 14 analysts. New target price is 59% above last closing price of UK£24.90. Stock is down 28% over the past year. The company is forecast to post a net loss per share of UK£0.0043 compared to earnings per share of UK£0.11 last year.Buying Opportunity • Feb 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be UK£33.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% per annum over the last 3 years. The company became loss making over the last year.Upcoming Dividend • Dec 30Upcoming dividend of UK£0.13 per shareEligible shareholders must have bought the stock before 06 January 2022. Payment date: 04 February 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.5%).Recent Insider Transactions Derivative • Dec 15Insider exercised options and sold UK£120k worth of stockOn the 13th of December, Lisa Johnston exercised options to acquire 4k shares at no cost and sold these for an average price of UK£32.72 per share. This trade did not impact their existing holding. Since September 2021, Lisa has owned 3.57k shares directly. Company insiders have collectively sold UK£4.5m more than they bought, via options and on-market transactions in the last 12 months.Reported Earnings • Nov 11First half 2022 earnings released: UK£0.27 loss per share (vs UK£0.13 loss in 1H 2021)The company reported a mediocre first half result with increased losses and weaker control over costs, although revenues improved. First half 2022 results: Revenue: UK£480.9m (up 45% from 1H 2021). Net loss: UK£81.5m (loss widened 302% from 1H 2021). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Board Change • Nov 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions Derivative • Oct 02Deputy CEO exercised options and sold UK£654k worth of stockOn the 28th of September, James Kidd exercised options to acquire 18k shares at no cost and sold these for an average price of UK£37.26 per share. This trade did not impact their existing holding. Since December 2020, James' direct individual holding has increased from 52.56k shares to 112.60k. Company insiders have collectively sold UK£3.9m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Sep 17CTO and Executive VP of R&D exercised options and sold UK£56k worth of stockOn the 14th of September, Andrew McCloskey exercised options to acquire 1k shares at no cost and sold these for an average price of UK£38.91 per share. This trade did not impact their existing holding. Since December 2020, Andrew's direct individual holding has increased from 594.00 shares to 2.37k. Company insiders have collectively sold UK£3.1m more than they bought, via options and on-market transactions in the last 12 months.Upcoming Dividend • Jul 01Upcoming dividend of UK£0.23 per shareEligible shareholders must have bought the stock before 08 July 2021. Payment date: 04 August 2021. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.6%).Recent Insider Transactions Derivative • Jul 01Chief Revenue Officer exercised options and sold UK£170k worth of stockOn the 28th of June, Steen Lomholt-Thomsen exercised options to acquire 5k shares at no cost and sold these for an average price of UK£37.43 per share. This trade did not impact their existing holding. Since December 2020, Steen's direct individual holding has increased from 3.60k shares to 6.41k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Jun 04Deputy CEO exercised options and sold UK£125k worth of stockOn the 2nd of June, James Kidd exercised options to acquire 4k shares at no cost and sold these for an average price of UK£34.85 per share. This trade did not impact their existing holding. Since September 2020, James' direct individual holding has increased from 47.06k shares to 105.03k. Company insiders have collectively sold UK£4.3m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • Jun 03CEO & Non-Executive Vice Chairman recently bought UK£479k worth of stockOn the 1st of June, Peter Herweck bought around 14k shares on-market at roughly UK£35.48 per share. This was the largest purchase by an insider in the last 3 months. Peter has been a buyer over the last 12 months, purchasing a net total of UK£268k worth in shares.Major Estimate Revision • Jun 01Consensus EPS estimates fall to UK£0.40The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from UK£1.27b to UK£1.25b. EPS estimate also fell from UK£0.59 to UK£0.40. Net income forecast to grow 357% next year vs 5.2% decline forecast for Software industry in the United Kingdom. Consensus price target broadly unchanged at UK£41.65. Share price rose 6.8% to UK£34.99 over the past week.Reported Earnings • May 27Full year 2021 earnings released: EPS UK£0.11 (vs UK£0.43 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: UK£820.4m (down 1.6% from FY 2020). Net income: UK£24.8m (down 65% from FY 2020). Profit margin: 3.0% (down from 8.4% in FY 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.Executive Departure • May 21Finance Director & Company Secretary has left the companyOn the 17th of May, David Ward's tenure as Finance Director & Company Secretary ended after 3.2 years in the role. As of March 2021, David personally held 10.84k shares (UK£371k worth at the time). David is the only executive to leave the company over the last 12 months.Recent Insider Transactions Derivative • Feb 26CEO & Executive Director exercised options and sold UK£1.1m worth of stockOn the 24th of February, Craig Hayman exercised options to acquire 32k shares at no cost and sold these for an average price of UK£35.51 per share. This trade did not impact their existing holding. For the year to March 2020, Craig's total compensation was 13% salary and 87% non-salary (Indicating these sales could comprise a meaningful part of their income for the year). Since December 2020, Craig's direct individual holding has increased from 69.83k shares to 124.15k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • Feb 13Finance Director & Company Secretary recently sold UK£152k worth of stockOn the 11th of February, David Ward sold around 4k shares on-market at roughly UK£37.75 per share. In the last 3 months, there was an even bigger sale from another insider worth UK£271k. Despite this recent sale, insiders have collectively bought UK£261k more than they sold in the last 12 months.Recent Insider Transactions • Jan 21Non-Executive Vice Chairman recently sold UK£271k worth of stockOn the 19th of January, Peter Herweck sold around 7k shares on-market at roughly UK£38.13 per share. This was the largest sale by an insider in the last 3 months. Peter has been a seller over the last 12 months, reducing personal holdings by UK£122k.Upcoming Dividend • Dec 31Upcoming Dividend of UK£0.12 Per ShareWill be paid on the 5th of February to those who are registered shareholders by the 7th of January. The trailing yield of 1.4% is below the top quartile of British dividend payers (4.7%), and is lower than industry peers (1.7%).Is New 90 Day High Low • Dec 01New 90-day low: UK£31.81The company is down 37% from its price of UK£50.34 on 02 September 2020. The British market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£17.96 per share.Price Target Changed • Nov 26Price target lowered to UK£39.56Down from UK£43.41, the current price target is an average from 11 analysts. The new target price is 19% above the current share price of UK£33.18. As of last close, the stock is down 27% over the past year.Recent Insider Transactions • Nov 20Deputy CEO recently bought UK£230k worth of stockOn the 16th of November, James Kidd bought around 6k shares on-market at roughly UK£41.69 per share. This was the largest purchase by an insider in the last 3 months. This was James' only on-market trade for the last 12 months.Major Estimate Revision • Nov 12Analysts lower EPS estimates to UK£0.33The 2021 consensus revenue estimate was lowered from UK£800.0m to UK£791.9m. Earning per share (EPS) estimate was also lowered from UK£0.44 to UK£0.33 for the same period. Net income is expected to grow by 127% next year compared to 12% decline forecast for the Software industry in the United Kingdom. The consensus price target was lowered from UK£44.84 to UK£43.66. Share price is down by 1.4% to UK£41.03 over the past week.Recent Insider Transactions • Nov 07Independent Non-Executive Director recently bought UK£163k worth of stockOn the 6th of November, Jennifer Allerton bought around 4k shares on-market at roughly UK£40.81 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£455k more in shares than they have sold in the last 12 months.Reported Earnings • Nov 07First half 2021 earnings released: UK£0.13 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£332.6m (down 15% from 1H 2020). Net loss: UK£20.3m (down 213% from profit in 1H 2020).Analyst Estimate Surprise Post Earnings • Nov 07Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.4%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 31% growth forecast for the Software industry in the United Kingdom.Is New 90 Day High Low • Nov 02New 90-day low: UK£41.81The company is down 1.0% from its price of UK£42.22 on 04 August 2020. The British market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£18.40 per share.決済の安定と成長配当データの取得安定した配当: AVVはUK市場で注目すべき配当金を支払っていないため、支払いが安定しているかどうかを確認する必要はありません。増加する配当: AVVはUK市場で注目すべき配当金を支払っていないため、支払額が増加しているかどうかを確認する必要はありません。配当利回り対市場AVEVA Group 配当利回り対市場AVV 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (AVV)1.2%市場下位25% (GB)2.2%市場トップ25% (GB)5.6%業界平均 (Software)2.6%アナリスト予想 (AVV) (最長3年)1.4%注目すべき配当: AVVの配当金 ( 1.17% ) はUK市場の配当金支払者の下位 25% ( 2.24% ) と比べると目立ったものではありません。高配当: AVVの配当金 ( 1.17% ) はUK市場の配当金支払者の上位 25% ( 5.64% ) と比較すると低いです。株主への利益配当収益カバレッジ: AVV UK市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: AVV UK市場において目立った配当金を支払っていません。高配当企業の発掘7D1Y7D1Y7D1YGB 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/01/20 20:23終値2023/01/18 00:00収益2022/09/30年間収益2022/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋AVEVA Group plc 11 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Gal MundaBerenbergNicholas GreenBernsteinFrederic Emile BoulanBofA Global Research8 その他のアナリストを表示
Upcoming Dividend • Jun 30Upcoming dividend of UK£0.24 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 05 August 2022. The company is not currently making a profit and its cash payout ratio is 85%. Trailing yield: 1.7%. Lower than top quartile of British dividend payers (5.2%). Lower than average of industry peers (2.2%).
Upcoming Dividend • Dec 30Upcoming dividend of UK£0.13 per shareEligible shareholders must have bought the stock before 06 January 2022. Payment date: 04 February 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.5%).
Upcoming Dividend • Jul 01Upcoming dividend of UK£0.23 per shareEligible shareholders must have bought the stock before 08 July 2021. Payment date: 04 August 2021. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.6%).
Upcoming Dividend • Dec 31Upcoming Dividend of UK£0.12 Per ShareWill be paid on the 5th of February to those who are registered shareholders by the 7th of January. The trailing yield of 1.4% is below the top quartile of British dividend payers (4.7%), and is lower than industry peers (1.7%).
お知らせ • Jan 19+ 5 more updatesAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share IndexAVEVA Group plc(LSE:AVV) dropped from FTSE techMARK All-Share Index
Recent Insider Transactions • Aug 03CTO and Executive VP of R&D recently sold UK£57k worth of stockOn the 26th of July, Andrew McCloskey sold around 2k shares on-market at roughly UK£23.11 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of UK£252k more than they bought in the last 12 months.
Upcoming Dividend • Jun 30Upcoming dividend of UK£0.24 per shareEligible shareholders must have bought the stock before 07 July 2022. Payment date: 05 August 2022. The company is not currently making a profit and its cash payout ratio is 85%. Trailing yield: 1.7%. Lower than top quartile of British dividend payers (5.2%). Lower than average of industry peers (2.2%).
Reported Earnings • Jun 09Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: UK£0.21 loss per share (down from UK£0.11 profit in FY 2021). Revenue: UK£1.19b (up 45% from FY 2021). Net loss: UK£62.6m (down 352% from profit in FY 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 12%, compared to a 26% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.
Board Change • Jun 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Anne Stevens was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Buying Opportunity • May 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be UK£26.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.
Price Target Changed • Apr 28Price target decreased to UK£33.83Down from UK£36.63, the current price target is an average from 16 analysts. New target price is 65% above last closing price of UK£20.54. Stock is down 42% over the past year. The company is forecast to post earnings per share of UK£0.072 for next year compared to UK£0.11 last year.
Buying Opportunity • Apr 27Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 32%. The fair value is estimated to be UK£27.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company became loss making.
Board Change • Mar 29High number of new directorsIndependent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021.
Recent Insider Transactions • Mar 11CTO and Executive VP of R&D recently sold UK£159k worth of stockOn the 7th of March, Andrew McCloskey sold around 7k shares on-market at roughly UK£24.03 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought UK£320k more than they sold in the last 12 months.
Price Target Changed • Feb 28Price target decreased to UK£39.60Down from UK£42.71, the current price target is an average from 14 analysts. New target price is 59% above last closing price of UK£24.90. Stock is down 28% over the past year. The company is forecast to post a net loss per share of UK£0.0043 compared to earnings per share of UK£0.11 last year.
Buying Opportunity • Feb 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be UK£33.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% per annum over the last 3 years. The company became loss making over the last year.
Upcoming Dividend • Dec 30Upcoming dividend of UK£0.13 per shareEligible shareholders must have bought the stock before 06 January 2022. Payment date: 04 February 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.5%).
Recent Insider Transactions Derivative • Dec 15Insider exercised options and sold UK£120k worth of stockOn the 13th of December, Lisa Johnston exercised options to acquire 4k shares at no cost and sold these for an average price of UK£32.72 per share. This trade did not impact their existing holding. Since September 2021, Lisa has owned 3.57k shares directly. Company insiders have collectively sold UK£4.5m more than they bought, via options and on-market transactions in the last 12 months.
Reported Earnings • Nov 11First half 2022 earnings released: UK£0.27 loss per share (vs UK£0.13 loss in 1H 2021)The company reported a mediocre first half result with increased losses and weaker control over costs, although revenues improved. First half 2022 results: Revenue: UK£480.9m (up 45% from 1H 2021). Net loss: UK£81.5m (loss widened 302% from 1H 2021). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Board Change • Nov 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Ayesha Khanna was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions Derivative • Oct 02Deputy CEO exercised options and sold UK£654k worth of stockOn the 28th of September, James Kidd exercised options to acquire 18k shares at no cost and sold these for an average price of UK£37.26 per share. This trade did not impact their existing holding. Since December 2020, James' direct individual holding has increased from 52.56k shares to 112.60k. Company insiders have collectively sold UK£3.9m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Sep 17CTO and Executive VP of R&D exercised options and sold UK£56k worth of stockOn the 14th of September, Andrew McCloskey exercised options to acquire 1k shares at no cost and sold these for an average price of UK£38.91 per share. This trade did not impact their existing holding. Since December 2020, Andrew's direct individual holding has increased from 594.00 shares to 2.37k. Company insiders have collectively sold UK£3.1m more than they bought, via options and on-market transactions in the last 12 months.
Upcoming Dividend • Jul 01Upcoming dividend of UK£0.23 per shareEligible shareholders must have bought the stock before 08 July 2021. Payment date: 04 August 2021. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.1%). Lower than average of industry peers (1.6%).
Recent Insider Transactions Derivative • Jul 01Chief Revenue Officer exercised options and sold UK£170k worth of stockOn the 28th of June, Steen Lomholt-Thomsen exercised options to acquire 5k shares at no cost and sold these for an average price of UK£37.43 per share. This trade did not impact their existing holding. Since December 2020, Steen's direct individual holding has increased from 3.60k shares to 6.41k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Jun 04Deputy CEO exercised options and sold UK£125k worth of stockOn the 2nd of June, James Kidd exercised options to acquire 4k shares at no cost and sold these for an average price of UK£34.85 per share. This trade did not impact their existing holding. Since September 2020, James' direct individual holding has increased from 47.06k shares to 105.03k. Company insiders have collectively sold UK£4.3m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • Jun 03CEO & Non-Executive Vice Chairman recently bought UK£479k worth of stockOn the 1st of June, Peter Herweck bought around 14k shares on-market at roughly UK£35.48 per share. This was the largest purchase by an insider in the last 3 months. Peter has been a buyer over the last 12 months, purchasing a net total of UK£268k worth in shares.
Major Estimate Revision • Jun 01Consensus EPS estimates fall to UK£0.40The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from UK£1.27b to UK£1.25b. EPS estimate also fell from UK£0.59 to UK£0.40. Net income forecast to grow 357% next year vs 5.2% decline forecast for Software industry in the United Kingdom. Consensus price target broadly unchanged at UK£41.65. Share price rose 6.8% to UK£34.99 over the past week.
Reported Earnings • May 27Full year 2021 earnings released: EPS UK£0.11 (vs UK£0.43 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: UK£820.4m (down 1.6% from FY 2020). Net income: UK£24.8m (down 65% from FY 2020). Profit margin: 3.0% (down from 8.4% in FY 2020). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.
Executive Departure • May 21Finance Director & Company Secretary has left the companyOn the 17th of May, David Ward's tenure as Finance Director & Company Secretary ended after 3.2 years in the role. As of March 2021, David personally held 10.84k shares (UK£371k worth at the time). David is the only executive to leave the company over the last 12 months.
Recent Insider Transactions Derivative • Feb 26CEO & Executive Director exercised options and sold UK£1.1m worth of stockOn the 24th of February, Craig Hayman exercised options to acquire 32k shares at no cost and sold these for an average price of UK£35.51 per share. This trade did not impact their existing holding. For the year to March 2020, Craig's total compensation was 13% salary and 87% non-salary (Indicating these sales could comprise a meaningful part of their income for the year). Since December 2020, Craig's direct individual holding has increased from 69.83k shares to 124.15k. Company insiders have collectively sold UK£4.4m more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • Feb 13Finance Director & Company Secretary recently sold UK£152k worth of stockOn the 11th of February, David Ward sold around 4k shares on-market at roughly UK£37.75 per share. In the last 3 months, there was an even bigger sale from another insider worth UK£271k. Despite this recent sale, insiders have collectively bought UK£261k more than they sold in the last 12 months.
Recent Insider Transactions • Jan 21Non-Executive Vice Chairman recently sold UK£271k worth of stockOn the 19th of January, Peter Herweck sold around 7k shares on-market at roughly UK£38.13 per share. This was the largest sale by an insider in the last 3 months. Peter has been a seller over the last 12 months, reducing personal holdings by UK£122k.
Upcoming Dividend • Dec 31Upcoming Dividend of UK£0.12 Per ShareWill be paid on the 5th of February to those who are registered shareholders by the 7th of January. The trailing yield of 1.4% is below the top quartile of British dividend payers (4.7%), and is lower than industry peers (1.7%).
Is New 90 Day High Low • Dec 01New 90-day low: UK£31.81The company is down 37% from its price of UK£50.34 on 02 September 2020. The British market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£17.96 per share.
Price Target Changed • Nov 26Price target lowered to UK£39.56Down from UK£43.41, the current price target is an average from 11 analysts. The new target price is 19% above the current share price of UK£33.18. As of last close, the stock is down 27% over the past year.
Recent Insider Transactions • Nov 20Deputy CEO recently bought UK£230k worth of stockOn the 16th of November, James Kidd bought around 6k shares on-market at roughly UK£41.69 per share. This was the largest purchase by an insider in the last 3 months. This was James' only on-market trade for the last 12 months.
Major Estimate Revision • Nov 12Analysts lower EPS estimates to UK£0.33The 2021 consensus revenue estimate was lowered from UK£800.0m to UK£791.9m. Earning per share (EPS) estimate was also lowered from UK£0.44 to UK£0.33 for the same period. Net income is expected to grow by 127% next year compared to 12% decline forecast for the Software industry in the United Kingdom. The consensus price target was lowered from UK£44.84 to UK£43.66. Share price is down by 1.4% to UK£41.03 over the past week.
Recent Insider Transactions • Nov 07Independent Non-Executive Director recently bought UK£163k worth of stockOn the 6th of November, Jennifer Allerton bought around 4k shares on-market at roughly UK£40.81 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£455k more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 07First half 2021 earnings released: UK£0.13 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£332.6m (down 15% from 1H 2020). Net loss: UK£20.3m (down 213% from profit in 1H 2020).
Analyst Estimate Surprise Post Earnings • Nov 07Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.4%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 31% growth forecast for the Software industry in the United Kingdom.
Is New 90 Day High Low • Nov 02New 90-day low: UK£41.81The company is down 1.0% from its price of UK£42.22 on 04 August 2020. The British market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£18.40 per share.